Breaking Through the Blood-Brain Barrier
Cognos' Mission for Improved Healthcare
Cognos Therapeutics innovates healthcare with SINNAIS, an implantable smart pump uniting a programmable pump, intraventricular catheter, and wireless communication. Targeting CNS diseases like LC cancer, pancreatic cancer, and glioblastoma, SINNAIS surpasses the blood-brain barrier. The estimated U.S. market size is significant at $15.8 billion annually, emphasizing LC, pancreatic cancer, and glioblastoma treatments.
Stay connected and get the latest company news delivered to your inbox.
NASDAQ: COGN
Cognos Therapeutics, Inc.
Price
Change
Volume
Day Range
52-week Range
Cognos Therapeutics Inc.'s Board of Directors, composed of prominent figures from business, medical research, and scientific technology, plays a vital role as custodians of the company's financial interests. They actively set policies to advance the company's objectives, fulfilling their fiduciary duty to investors.
Corporate Headquarters
Cognos Therapeutics, Inc.
10604 S La Cienega Blvd.
Inglewood, CA 90304
310.641.2700
info@cognosthx.com
Investor Relations
Gilmartin Group
San Francisco
60 E Sir Francis Drake Blvd, Suite 208
Larkspur, CA 94939
info@gilmartinir.com
Transfer Agent
Continental Stock Transfer and Trust
1 State Street, 30th Floor
New York, NY 10004-1561
212.509.4000
cstmail@continentalstock.com